Global Hydroxychloroquine Sulphate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hydroxychloroquine Sulphate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
Hydroxychloroquine Sulphate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hydroxychloroquine Sulphate market is projected to reach US$ 1004.8 million in 2034, increasing from US$ 879.4 million in 2022, with the CAGR of 1.9% during the period of 2024 to 2034. Demand from Lupus Erythematosus and Rheumatoid Arthritis are the major drivers for the industry.
The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hydroxychloroquine Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Segment by Type
100mg
200mg
Others
Lupus Erythematosus
Rheumatoid Arthritis
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hydroxychloroquine Sulphate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hydroxychloroquine Sulphate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hydroxychloroquine Sulphate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hydroxychloroquine Sulphate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hydroxychloroquine Sulphate introduction, etc. Hydroxychloroquine Sulphate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hydroxychloroquine Sulphate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.
Hydroxychloroquine Sulphate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hydroxychloroquine Sulphate market is projected to reach US$ 1004.8 million in 2034, increasing from US$ 879.4 million in 2022, with the CAGR of 1.9% during the period of 2024 to 2034. Demand from Lupus Erythematosus and Rheumatoid Arthritis are the major drivers for the industry.
The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hydroxychloroquine Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Segment by Type
100mg
200mg
Others
Segment by Application
Lupus Erythematosus
Rheumatoid Arthritis
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hydroxychloroquine Sulphate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hydroxychloroquine Sulphate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hydroxychloroquine Sulphate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hydroxychloroquine Sulphate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hydroxychloroquine Sulphate introduction, etc. Hydroxychloroquine Sulphate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hydroxychloroquine Sulphate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.